Clinical Trial

Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

Name: Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis (SAR) — clinical trial record (NCT07617324)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a multicenter, single-arm, open-label, phase II study to evaluate the safety, pharmacokinetics, and immunogenicity of Stapokibart injection in Adolescent Patients with SAR.

Trial Details

NCT Number	NCT07617324
Lead Sponsor	Chengdu Kangnuoxing Biopharma,Inc.
Conditions	Seasonal Allergic Rhinitis (SAR)
Enrollment	15 participants
Start Date	2026-06
Primary Completion	2026-10 (estimated)
Study Completion	2027-02 (estimated)
Updated on ClinicalTrials.gov	2026-06-01